Literature DB >> 11930609

[The prevalence and mechanism of Helicobacter pylori resistance to clarithromycin in Beijing].

X Zheng1, F Hu, W Wang.   

Abstract

OBJECTIVE: (1) To determine the prevalence of Helicobacter pylori strains resistant to clarithromycin in Peking. (2) To determine the genetic mutation in relation to clarithromycin resistance.
METHODS: Helicobacter pylori were cultured from gastric biopsies obtained from 89 patients during upper endoscopy. Minimal inhibitory concentrations of clarithromycin were determined by Etest method. Genomic DNA was prepared by the hexadecyltrimethylammonium bromide (CTAB)-phenol extraction method. Mutations in clarithromycin-resistant strains were identified by polymerase chain reaction and restrictions analysis.
RESULTS: (1) The prevalence of Helicobacter pylori strains resistant to clarithromycin was 13.5% in Beijing. (2) All twelve clarithromycin-resistant strains had the new BsaI site which is characteristic of the A2143G point mutation in 23S rRNA gene, none of the tested twenty-four susceptible strains had the A2142G or A2143G mutation.
CONCLUSION: The prevalence of clarithromycin-resistant strains was not rare in Beijing. Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11930609

Source DB:  PubMed          Journal:  Zhonghua Yi Xue Za Zhi        ISSN: 0376-2491


  2 in total

1.  Detection of the clarithromycin resistance of Helicobacter pylori in gastric mucosa by the amplification refractory mutation system combined with quantitative real-time PCR.

Authors:  Xiao-Yan Zhang; Wei-Xiang Shen; Chun-Feng Chen; Hai-Hui Sheng; Hong Cheng; Jiang Li; Fulian Hu; Da-Ru Lu; Heng-Jun Gao
Journal:  Cancer Med       Date:  2019-03-12       Impact factor: 4.452

2.  Prevalence of A2143G mutation of H. pylori-23S rRNA in Chinese subjects with and without clarithromycin use history.

Authors:  Zhuoqi Liu; Jing Shen; Lian Zhang; Lin Shen; Qiang Li; Baozhen Zhang; Jing Zhou; Liankun Gu; Guoshuang Feng; Junling Ma; Wei-Cheng You; Dajun Deng
Journal:  BMC Microbiol       Date:  2008-05-28       Impact factor: 3.605

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.